ADVERTISEMENT

Lupin gets US regulator nod for diabetes drug

Drug major Lupin today said it has received US health regulator's approval to sell its generic version of Glumetza HCl ER Tablets, a diabetes drug, in the American market. The company's US-based subsidiary Lupin Pharmaceuticals Inc has received final approval from US Food and Drug Administration (USFDA) for its Metformin Hydrochloride extended release tablets in strengths of 500 mg and 1000 mg, Lupin Ltd said in a statement. ...
Register for Free
to continue reading
OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit